Hanmi Pharm. Co., Ltd.
Symbol: 128940.KS
KSC
322000
KRWMarket price today
24.3478
P/E Ratio
0.0155
PEG Ratio
4.09T
MRK Cap
- 0.00%
DIV Yield
Hanmi Pharm. Co., Ltd. (128940-KS) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 254155.7 | 236736.4 | 211734.4 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 199175.4 | 89407.8 | 2509.7 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 179195.9 | 191163.2 | 241982 | ||||||||||||||
balance-sheet.row.inventory | 0 | 288813.8 | 266185.4 | 250188.7 | ||||||||||||||
balance-sheet.row.other-current-assets | 0 | 26487.6 | 73.2 | 56.5 | ||||||||||||||
balance-sheet.row.total-current-assets | 0 | 748652.9 | 694158.3 | 703961.6 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 860242 | 917981.5 | 957218.2 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.long-term-investments | 0 | 47756 | -17742 | 50416.9 | ||||||||||||||
balance-sheet.row.tax-assets | 0 | 159972 | 89901.6 | 91855.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 54367 | 155699.5 | 53106.5 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1203382.2 | 1230427.5 | 1232767.1 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.account-payables | 0 | 45180.3 | 39709.5 | 42833.4 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 483775.4 | 489193 | 455166.9 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 6741.6 | 22180.1 | 26475 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 82028.4 | 225815.6 | 301099.8 | ||||||||||||||
Deferred Revenue Non Current | 0 | 1033.1 | 8457.6 | 10839.7 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0 | 150970.5 | 131195.3 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 146408.2 | 238610.7 | 359531 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 7063.4 | 48215.1 | 65622.2 | ||||||||||||||
balance-sheet.row.total-liab | 0 | 851824.4 | 915359 | 1008469.3 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 0 | 31405.4 | 30794.9 | 30195.7 | ||||||||||||||
balance-sheet.row.retained-earnings | 0 | 336059.3 | 452297.5 | 396915.9 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 216059.6 | 232729.4 | 200479.4 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 371918.2 | 156043.8 | 175322.8 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 955442.4 | 871865.6 | 802913.7 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 144768.3 | 137361.1 | 125345.7 | ||||||||||||||
balance-sheet.row.total-equity | 0 | 1100210.6 | 1009226.7 | 928259.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||
Total Investments | 0 | 246931.4 | 71665.7 | 52926.7 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 572867.3 | 715008.6 | 756266.7 | ||||||||||||||
balance-sheet.row.net-debt | 0 | 517886.9 | 567680 | 547042.1 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 146231.2 | 101558.2 | 81478.2 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 98454 | 96842 | 89086.3 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -57396.6 | -73686.3 | -53516.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -2602.8 | 38190.1 | -74313.9 | ||||||||||||||
cash-flows.row.inventory | 0 | -16902.6 | -14365.3 | 18915.7 | ||||||||||||||
cash-flows.row.account-payables | 0 | 5574.2 | -2736.1 | 9794.1 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -43465.5 | -94774.9 | -7912.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 29249.1 | 37555 | 84874.8 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 2600.2 | -25772 | -14112.3 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -94770.2 | -92923.2 | -7738.6 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 90377.5 | 86.6 | 785.9 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | -133933.2 | -13206.4 | 12101.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -183472.2 | -181408.1 | -43388.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -103371 | -260971.4 | -232371.4 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 93.5 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3070.6 | -3834.1 | -4873.5 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | -17995.6 | -5992.2 | -5881.3 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2443 | 233930.9 | 129795.6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -126786.7 | -36866.8 | -113330.6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1372.9 | -5890 | 17863.5 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -92348.3 | -61896 | 63067.3 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 54980.3 | 147328.7 | 209224.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 147328.7 | 209224.6 | 146157.4 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 216537.6 | 162268.9 | 201923.2 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | 168791.1 | 112675.9 | 167498.3 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1490887.5 | 1331546.6 | 1203185.7 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 655030.7 | 612993.5 | 570433.4 | ||||||||||||||
income-statement-row.row.gross-profit | 0 | 835856.7 | 718553.1 | 632752.2 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.operating-expenses | 0 | 610971.8 | 560462.7 | 507336.4 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1266002.5 | 1173456.3 | 1077769.8 | ||||||||||||||
income-statement-row.row.interest-income | 0 | 4617.7 | 7856.4 | 5722.3 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 98454 | 97942.5 | 87056.1 | ||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 0 | 224884.9 | 158090.3 | 125415.9 | ||||||||||||||
income-statement-row.row.income-before-tax | 0 | 195267.6 | 121012.5 | 103696.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 28600.6 | 19454.3 | 22218.3 | ||||||||||||||
income-statement-row.row.net-income | 0 | 146231.2 | 82791.7 | 67025.4 |
Frequently Asked Question
What is Hanmi Pharm. Co., Ltd. (128940.KS) total assets?
Hanmi Pharm. Co., Ltd. (128940.KS) total assets is 1952035090968.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.671.
What is company free cash flow?
The free cash flow is 13515.617.
What is enterprise net profit margin?
The net profit margin is 0.108.
What is firm total revenue?
The total revenue is 0.158.
What is Hanmi Pharm. Co., Ltd. (128940.KS) net profit (net income)?
The net profit (net income) is 146231157740.000.
What is firm total debt?
The total debt is 572867266550.000.
What is operating expences number?
The operating expences are 610971802715.000.
What is company cash figure?
Enretprise cash is 0.000.